The implementation of LTBI therapy revealed a 7-fold higher likelihood of TB reactivation in those exposed to TNF inhibitors therapy who did not follow guidelines for latent TB treatment, and a 78% reduction in the rate of active TB cases among those who did [29,35]. Here, TNF is linked to tuberculosis.